Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,649 | -6,753 | -13,879 | -9,002 | -5,602 |
| Depreciation Amortization | -21 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,853 | 189 | 207 | 189 | -277 |
| Other Working Capital | 3,259 | 672 | 1,679 | 555 | 1 |
| Other Operating Activity | -121 | 688 | 3,808 | 2,966 | 2,526 |
| Operating Cash Flow | $-10,679 | $-5,204 | $-8,185 | $-5,292 | $-3,352 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,965 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-9,965 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6 | 6 | 7,241 | 7,296 | 12 |
| Other Financing Activity | -24 | 0 | 0 | 0 | -156 |
| Financing Cash Flow | $-18 | $6 | $7,241 | $7,296 | $-144 |
| Beginning Cash Position | 41,100 | 41,100 | 42,044 | 42,044 | 42,044 |
| End Cash Position | 20,438 | 35,902 | 41,100 | 44,048 | 38,548 |
| Net Cash Flow | $-20,662 | $-5,198 | $-944 | $2,004 | $-3,496 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,679 | -5,204 | -8,185 | -5,292 | -3,352 |
| Free Cash Flow | -10,679 | -5,204 | -8,185 | -5,292 | -3,352 |